All Stories

  1. Peritoneal pseudomyxoma after incomplete appendectomy

    Article • Pleura and Peritoneum, August 2020, De Gruyter

    Marc Pocard

  2. “Peritoneal failure”: A new concept to explain negative results of randomized trials evaluating intraperitoneal therapies

    Article • Pleura and Peritoneum, May 2020, De Gruyter

    Marc Pocard, Marc Reymond

  3. Bidirectional chemotherapy combining intraperitoneal docetaxel with intravenous 5-fluorouracil and oxaliplatin for patients with unresectable peritoneal metastasis from gastric cancer: the first study in Western countries

    Article • Pleura and Peritoneum, April 2020, De Gruyter

    Marc Pocard

  4. MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma

    Article • Pleura and Peritoneum, June 2019, De Gruyter

    Marc Pocard, Nabila bouazza

  5. Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature

    Article • Pleura and Peritoneum, May 2019, De Gruyter

    Marc Pocard

  6. Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review

    Article • Pleura and Peritoneum, December 2018, De Gruyter

    Marc Pocard

  7. Medical devices for treating peritoneal metastasis in low-income countries: is less more?

    Article • Pleura and Peritoneum, December 2017, De Gruyter

    Marc Pocard

  8. Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy

    Article • Pleura and Peritoneum, January 2017, De Gruyter

    Marc Pocard

  9. peritoneal cancer translational reearch

    Article • Pleura and Peritoneum, January 2016, De Gruyter

    Marc Pocard